To mark the completion of the #PRISMAP project, a press release providing an overview of the user projects funded by our European programme for medical radionuclides has just been published.
The primary goal of the project was to enable emerging European research infrastructures to use high-purity radionuclides for medical purposes. It brought together 23 partners from 13 European countries, one European Research Laboratory, and an international organization, and benefited from the support of the European Association for Nuclear Medicine (EANM) and the International Atomic Energy Agency (IAEA).
A proposal for funding a follow-up project called PRISMAP+ has been submitted to the European Commission in September 2025. Evaluation results are expected by the end of February 2026.
The press release includes a delivery map where you can track all radionuclide deliveries made during the project’s lifetime.
Enjoy reading!
